Roger G. Stoll
University of Connecticut
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Roger G. Stoll.
The Journal of Clinical Pharmacology | 1982
Avraham Yacobi; Roger G. Stoll; Check Y. Sum; Chii-Ming Lai; Surinder D. Gupta; James D. Hulse
Abstract: To determine the elimination of high‐molecular‐weight hydroxyethyl starch (HES, Mw 450,000) in normal subjects, ten volunteers were given 500 ml 6% HES solution by intravenous infusion, and serial blood and urine samples were collected for nonglucose total carbohydrate determination. On the average, 46 and 64 per cent of the dose was excreted in the urine within two and eight days, respectively. The plasma concentration declined rapidly during the first week after infusion. The average terminal half‐life was 17 days during the first 42 days, which accounted for elimination of about 90 per cent of the dose. The remainder was eliminated with a terminal half‐life of 48 days determined between days 42 and 83 of the study. As expected, the infusion of HES resulted in plasma volume expansion over a 48‐hour period during which time levels of nonglucose carbohydrates were above 3.5 mg/ml. HES is metabolized by α‐amylase in the body. During the first 48 hours after infusion of HES, plasma α‐amylase activity was significantly increased over control. Concomitantly, α‐amylase activity in urine was also elevated but not significantly so.
Drug Development and Industrial Pharmacy | 1981
James Swarbrick; Roger G. Stoll
AbstractA survey has been made of 12 U.S. and 5 U.K. companies in order to establish if there are any favored organizational structures in terms of pilot plant and related operations, production trouble shooting, clinical supplies manufacture and general engineering support services. Broad patterns of behavior become apparent in terms of the manner in which companies organize themselves to perform these functions. Communication, background and training of personnel and well-drawn lines of responsibility emerge as important factors in the efficient operation of the organizations surveyed.This survey was undertaken in order to establish if there are any favored organizational structures in terms of pilot plant and related operations, production trouble shooting, clinical supplies manufacture, and general engineering support services. Senior Research and Development and Manufacturing personnel in 12 U.S. and 5 U.K. companies were contacted individually and asked to participate. The confidentiality of the sur...
Journal of Pharmaceutical Sciences | 1979
Chii-Ming Lai; Avraham Yacobi; Roger G. Stoll; Zee M. Look
Journal of Pharmaceutical Sciences | 1980
Avraham Yacobi; Roger G. Stoll; George C. Chao; James E. Carter; David M. Baaske; Burde L. Kamath; Anton H. Amann; Chii-Ming Lai
Journal of Pharmaceutical Sciences | 1969
Roger G. Stoll; Theodore R. Bates; Karl A. Nieforth; James Swarbrick
Journal of Pharmaceutical Sciences | 1973
Roger G. Stoll; Theodore R. Bates; James Swarbrick
Journal of Pharmaceutical Sciences | 1981
A. Waseem Malick; Anton H. Amann; David M. Baaske; Roger G. Stoll
Journal of Pharmaceutical Sciences | 1978
Roger G. Stoll; George C. Chao; Harvey J. Hoyt; Avraham Yacobi
Journal of Pharmaceutical Sciences | 1969
Louis Decato; Marvin H. Malone; Roger G. Stoll; Karl A. Nieforth
Archive | 1982
Avraham Yacobi; Roger G. Stoll; Check V. Sum; Chii-Ming Lai; Surinder D. Gupta; James D. Hulse